Weise Susanne, Oravcová Mária, Hanslik Pauline, Mignot Coralie, Cakmak Yusuf Ozgur, Hummel Thomas
Smell & Taste Clinic, Department of Otorhinolaryngology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01099, Dresden, Sachsen, Germany.
Point-of-Care Technologies Theme, Centre for Bioengineering and Nanotechnology, Dunedin, New Zealand.
Eur Arch Otorhinolaryngol. 2025 Oct 18. doi: 10.1007/s00405-025-09701-5.
Previous studies in healthy individuals showed that high-frequency but not the low frequency non-invasive vagal nerve stimulation improves olfactory function in healthy individuals. The present study aimed to analyze the potential effects of non-invasive, high-frequency transcutaneous auricular vagal nerve stimulation (TA-VNS) on olfactory function in patients with olfactory dysfunction (OD) and healthy individuals.
Patients with post-COVID-19 associated OD (n = 10) and normosmic individuals (n = 30) performed olfactory testing (Sniffin` Sticks), trigeminal testing (lateralization test), attentional tests (d2 test), ratings of odor intensity and pleasantness before and after receiving a TA-VNS for 10 min. Patients with OD received only TA-VNS while normosmic subjects underwent, in addition to TA-VNS, placebo stimulation (control condition) with electrode placement of TA-VNS, and active-control transcutaneous stimulation at the forearm in a randomized order with a minimum 24-h interval between sessions.
In patients with OD intensity ratings for fish and pleasantness ratings for eucalyptol increased and olfactory discrimination improved (p = 0.017) as opposed to olfactory threshold (p = 0.18). For both, patients with OD and healthy individuals results of the d2 attention test improved following the TA-VNS. In healthy individuals, there were no differences in olfactory discrimination nor threshold regarding the 3 stimulation modalities (TA-VNS, placebo (control condition), transcutaneous stimulation).
These results seem to underline the functional connection of the olfactory system with the afferent vagus network. However, a ceiling effect for olfactory discrimination did not allow to observe a possible improvement in normosmic individuals. Further studies in patients with OD are needed to characterize this potential therapeutic effect of TA-VNS.
先前针对健康个体的研究表明,高频而非低频非侵入性迷走神经刺激可改善健康个体的嗅觉功能。本研究旨在分析非侵入性高频经皮耳迷走神经刺激(TA-VNS)对嗅觉功能障碍(OD)患者和健康个体嗅觉功能的潜在影响。
新冠后相关OD患者(n = 10)和嗅觉正常个体(n = 30)在接受10分钟TA-VNS前后进行嗅觉测试(嗅棒测试)、三叉神经测试(定位测试)、注意力测试(d2测试)、气味强度和愉悦度评分。OD患者仅接受TA-VNS,而嗅觉正常受试者除TA-VNS外,还接受TA-VNS电极放置的安慰剂刺激(对照条件),以及在前臂进行的主动对照经皮刺激,以随机顺序进行,各疗程之间至少间隔24小时。
与嗅觉阈值(p = 0.18)相比,OD患者中鱼的强度评分和桉叶醇的愉悦度评分增加,嗅觉辨别能力提高(p = 0.017)。对于OD患者和健康个体,TA-VNS后d2注意力测试结果均有所改善。在健康个体中,三种刺激方式(TA-VNS、安慰剂(对照条件)、经皮刺激)在嗅觉辨别或阈值方面均无差异。
这些结果似乎强调了嗅觉系统与传入迷走神经网络的功能联系。然而,嗅觉辨别能力的天花板效应使得无法观察到嗅觉正常个体可能的改善情况。需要对OD患者进行进一步研究,以明确TA-VNS的这种潜在治疗效果。